Table 8.
Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|
|
|||||
N | HR (95% CI) | P-value | HR (95% CI) | P-value | |
Age | |||||
< 55 | 88 | 0.869 (0.195-3.886) | 0.855 | ||
≥ 55 | 16 | ||||
Therapy | |||||
Operation | 19 | 28.268 (0.098-8.183) | 0.248 | ||
Operation+others | 85 | ||||
Stromal invasion | |||||
Negative | 44 | 10.552 (1.380-80.693) | 0.023 | 3.756 (0.416-33.934) | 0.239 |
Positive | 60 | ||||
Vaginal wall extension | |||||
Negative | 85 | 1.765 (0.553-5.631) | 0.337 | 0.873 (0.243-3.142) | 0.835 |
Positive | 19 | ||||
Parametrial extension | |||||
Negative | 99 | 1.495 (0.195-11.439) | 0.698 | ||
Positive | 5 | ||||
Intravascular space involvement | |||||
Absent | 58 | 1.253 (0.439-3.573) | 0.674 | ||
Present | 46 | ||||
Lymph node metastasis | |||||
Negative | 76 | 7.363 (2.307-23.499) | 0.001 | 5.134 (1.514-17.415) | 0.009 |
Positive | 28 | ||||
Histological type | |||||
SCC | 93 | 1.352 (0.302-6.040) | 0.693 | ||
ADC+ASC | 11 | ||||
Stage | |||||
Early (in situ, I) | 80 | 4.267 (1.337-13.619) | 0.014 | 2.248 (0.621-8.137) | 0.217 |
Advanced(II, III, IV) | 24 | ||||
Caspase-3 | |||||
Low | 93 | 7.478 (2.585-21.632) | <0.001 | 4.208 (1.373-12.894) | 0.012 |
High | 11 |
Abbreviation: ADC+ASC: adenocarcinoma+adenosquamous carcinoma.